We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > D614G

News List

Avacta’s Rapid Antigen Test Confirmed to Detect SARS-CoV-2 New Variants americanpharmaceuticalreview
March 16, 2021
Avacta has announced the AffiDX® SARS-CoV-2 rapid antigen lateral flow test detects the dominant new variants of the coronavirus, known as the B117, or ‘Kent’, variant, and the D614G variant, as well as the original strain.
New COVID-19 strain dominates global cases of virus, it is more infectious but not more severe expresspharma
July 06, 2020
The variant, named ‘D614G’, makes a small but effective change in the ‘spike’ glycoprotein that protrudes from the surface of the virus, which it uses to enter and infect human cells.
Newer variant of COVID-19-causing virus dominates global infections worldpharmanews
July 03, 2020
Research out today in the journal Cell shows that a specific change in the SARS-CoV-2 coronavirus virus genome, previously associated with increased viral transmission and the spread of COVID-19, is more infectious in cell culture.